We believe that new medicines could be created to combat breast cancer and other breast diseases with further studies involving LEP. Overall, our study suggested that LEP can be used as a positive prognostic biomarker and a potential therapeutic target in breast cancer. The gene discussed is LEP; the disease is breast cancer.